Covid Vaccine Class Action



Nature and Scope of the Matter

This matter relates to the conduct of the Therapeutic Goods Administration, with the relevant respondents being (at least) the Australian Government, the Department of Health and Aged Care Secretary Dr Brendan Murphy and the Deputy Secretary of Health Products Regulation Group Adjunct Professor John Skerrit. The Class Action has been brought by a class of persons across Australian jurisdictions who are COVID-19 vaccine injured parties. 

The procedural rules for class actions in the FCA are set out in:

  1. Division 9.3 of the Federal Court Rules 2011 (Cth);
  1. Part IVA of the Federal Court of Australia Act 1976 (Cth); and
  1. The Federal Court of Australia Class Actions Practice Note GPN-CA.

The action has been instituted by the Lead Applicants on their own behalf and on behalf of the Group Members – those who have similar claims to the applicant against the respondent. The relevant legislation requires that there are at least seven class members, but not all members need to be named in the original application.

Class action proceedings typically function on an “opt-out” basis, meaning that all members who have elected to join the Class Action will be bound by the Class Action’s outcome unless they opt-out by a date set by the Court. An opt-out notice will become available on our website once the Court sets this date.

It is important to note that potential causes of action lie in negligence and malfeasance of the proposed respondents named above.  If a class member opts out of the Class Action, they may be able to commence separate litigation in their State or Territory.

If you wish to proceed as a Group Member in the Class Action on the basis outlined in the Letter to Group Members Above, We kindly ask that you complete the details for and execute the Agreement below